Utilization of Surveillance Colonoscopy in Community Practice

Gastroenterology

Volumn 138, Issue 1, 2010, Pages 73-81

  Schoen, Robert E ^a   Pinsky, Paul F ^b   Weissfeld, Joel L ^a   Yokochi, Lance A ^c   Reding, Douglas J ^d   Hayes, Richard B ^b   Church, Timothy ^e   Yurgalevich, Susan ^f   Doria Rose, V Paul ^b   Hickey, Tom ^g   Riley, Thomas ^g   Berg, Christine D ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^d MARSHFIELD CLINIC   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f WESTAT   (United States)

^g INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMMUNITY CARE; FAMILY HISTORY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY;

EID: 72249084929     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.09.062     Document Type: Article

References (23)

1. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 137 (2002) 129-131
2. Winawer S., Fletcher R., Rex D., et al. Gastrointestinal Consortium. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003) 544-560
3. Colorectal cancer screening. Recommendation statement from the Canadian task force on preventive health care. Can Fam Physician 47 (2001) 1811-1815
4. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 (1993) 1977-1981
5. Mandel J.S., Church T.R., Bond J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000) 1603-1607
6. Lieberman D.A., De Garmo P.L., Fleischer D.E., et al. Patterns of endoscopy use in the United States. Gastroenterology 118 (2000) 619-624
7. Ladabaum U., and Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology 129 (2005) 1151-1162
8. Vijan S., Inadomi J., Hayward R.A., et al. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther 20 (2004) 507-515
9. Winawer S.J., Zauber A.G., Fletcher R.H., et al., US Multi-Society Task Force on Colorectal Cancer, American Cancer Society. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 130 (2006) 1872-1875
10. Boolchand V., Olds G., Singh J., et al. Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med 145 (2006) 654-659
11. Mysliwiec P.A., Brown M.L., Klabunde C.N., et al. Are physicians doing too much colonoscopy?. A national survey of colorectal surveillance after polypectomy. Ann Intern Med 141 (2004) 264-271
12. Weissfeld J.L., Schoen R.E., Pinsky P.F., et al., PLCO Project Team. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 97 (2005) 989-997
13. Pinsky P.F., Schoen R.E., Weissfeld J.L., et al. The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol 7 (2009) 86-92
14. Prorok P.C., Andriole G.L., Bresalier R.S., et al., Prostate Lung Colorectal and Ovarian Cancer Screening Trial Project Team. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21 Suppl (2000) 309S
15. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
16. Singh H., Turner D., Xue L., Targownik L.E., and Bernstein C.N. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 295 (2006) 2366-2373
17. Pignone M., Saha S., Hoerger T., et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 96-104
18. Atkin W.S., Morson B.C., and Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. [see comments]. N Engl J Med 326 (1992) 658-662
19. Schoen R.E. Surveillance after positive and negative colonoscopy examinations: issues, yields, and use. Am J Gastroenterol 98 (2003) 1237-1246
20. Laiyemo A.O., Murphy G., Albert P.S., et al. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med 148 (2008) 419-426
21. Laiyemo A.O., Pinsky P.F., Marcus P.M., et al. Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol 7 (2009) 562-567
22. Pinsky P.F., Miller A., Kramer B.S., et al. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol 165 (2007) 874-881
23. Lieberman D.A., Weiss D.G., Harford W.V., et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 133 (2007) 1077-1085